In Moderate to severe pain Ultrin Semi Tablet effectively relieves moderate to severe pain in conditions like menstrual cramp, arthritis, headache, muscle aches if taken when the first signs of pain occur. It works by reducing substances in the body that causes pain. This gives relief from pain and discomfort and thus improves the quality of your life. Take Ultrin Semi Tablet by mouth as directed by your doctor.
It is unsafe to consume alcohol with Ultrin Semi Tablet.
Ultrin Semi Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Ultrin Semi Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Consult a doctor immediately if the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing problems, or limpness.
Ultrin Semi Tablet may cause side effects which could affect your ability to drive.
Ultrin Semi Tablet should be used with caution in patients with kidney disease. Dose adjustment of Ultrin Semi Tablet may be needed. Please consult your doctor.
Ultrin Semi Tablet should be used with caution in patients with liver disease. Dose adjustment of Ultrin Semi Tablet may be needed. Please consult your doctor. However, the use of Ultrin Semi Tablet is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Ultrin Semi Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Crescent Therapeutics Ltd || ₹14.5/tablet (25% cheaper)